RPL11: Ribosomal Protein L11

A key component of the large ribosomal subunit implicated in Diamond-Blackfan anemia and cancer

Gene Information Card

Symbol RPL11
Full Name Ribosomal Protein L11
Gene Type protein-coding
Chromosomal Location 1p36.11
NCBI Gene ID 6135 ncbi.nlm.nih.gov/gene/6135
Ensembl ID ENSG00000142676
UniProt ID P62913
OMIM ID 180466
HGNC ID 10301
Aliases L11, uL11, DBA7, eL11

Description

RPL11 encodes a ribosomal protein that is a component of the 60S large ribosomal subunit. The protein binds to MDM2, inhibiting its ability to degrade p53, thereby linking ribosomal stress to the p53 tumor suppressor pathway. Mutations in RPL11 cause Diamond-Blackfan anemia type 7 (DBA7), a congenital bone marrow failure syndrome. RPL11 is also implicated in various cancers through dysregulation of ribosome biogenesis and p53 signaling.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Diamond-Blackfan anemia 7 (DBA7) Loss-of-function mutations impair ribosome assembly, leading to erythroid hypoplasia and p53-mediated apoptosis. OMIM #612562; ClinVar
Colorectal cancer RPL11 haploinsufficiency may promote tumorigenesis via p53 inactivation. COSMIC; PMID: 23583978
Breast cancer Altered RPL11 expression correlates with poor prognosis and p53 pathway disruption. PMID: 25605274
Myelodysplastic syndromes RPL11 mutations are recurrent in MDS with del(5q) and contribute to p53 activation. PMID: 23160464

Expression Profile

Tissue Expression
Tissue nTPM level
Bone marrow 25.3 High
Lymph node 22.1 High
Spleen 20.8 High
Testis 18.5 High
Brain 12.4 Medium
Liver 10.2 Medium
Heart 8.7 Low
Cell Line Expression
Cell Line nTPM Notes
K562 (leukemia) 28.1 High expression
HeLa (cervical) 24.6 High expression
HEK293 (embryonic kidney) 22.3 High expression
MCF7 (breast cancer) 19.8 Medium expression
HepG2 (liver cancer) 17.5 Medium expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.94C>T (p.Arg32Ter) Nonsense Rare (DBA) Loss of function; premature termination
c.175_176delAG (p.Ser59fs) Frameshift Rare (DBA) Loss of function; truncated protein
c.208G>A (p.Gly70Arg) Missense Rare (DBA) Loss of function; impaired MDM2 binding
c.346A>G (p.Thr116Ala) Missense Somatic (cancer) Unknown; possibly gain of function
Mutation functional classification

Loss of Function (LOF)

Nonsense, frameshift, and missense mutations that reduce RPL11 protein levels or impair ribosome assembly and MDM2 binding, leading to p53 activation and Diamond-Blackfan anemia.

Gain of Function (GOF)

Not well characterized; some somatic missense variants may alter MDM2 interaction, potentially promoting cell survival.

Dominant Negative (DN)

Haploinsufficiency is the primary mechanism in DBA; no clear dominant-negative mutations reported.

Pathways

Ribosome (KEGG hsa03010)
p53 signaling pathway (KEGG hsa04115)
MDM2-p53 pathway (Reactome R-HSA-6804757)
rRNA processing in the nucleus and cytosol (Reactome R-HSA-8868773)

Protein Summary

Ribosomal protein L11 (uL11) is a 178-amino-acid protein that localizes to the 60S ribosomal subunit. It contains an RNA-binding domain and a zinc finger-like motif. Beyond its role in translation, RPL11 functions as a sentinel for ribosomal stress: upon impaired ribosome biogenesis, free RPL11 binds MDM2, preventing p53 ubiquitination and degradation, leading to cell cycle arrest or apoptosis. This makes RPL11 a critical tumor suppressor link.

Related Products

Product name Cat.No. Species Gene ID
Contact Us
*
*
*
*
How did you hear about us: